The US National Kidney Foundation did not recommend routine administration of L-carnitine to subjects undergoing dialysis yet encouraged the development of trials in patients with select symptoms that do not respond to standard therapy, i.e., persistent muscle cramps or hypotension during dialysis, severe fatigue, skeletal muscle weakness or myopathy, cardiomyopathy, and anemia requiring large doses of erythropoietin (74, 75)
In fact, some legal experts suggest that simply prescribing BPC-157 is malpractice per se, since its impossible to adequately inform a patient of risks that havent been studied
Psychiatry 76 , 550558 (2014)
This process often includes the addition of mannitol , a stabilising agent that helps protect the peptide
Yes, this supplement is formulated to be beneficial for all skin types